Friday, August 5, 2022 - Artivion Inc (AORT) reported upside earnings and revenues today.
The consensus among analysts for Artivion Inc was for an earnings per share (EPS) loss of $0.11 per share. The firm was able to surpass those projections, reporting an EPS loss of $0.03 per share, a positive surprise of $0.08 (73%). Profits fell 125% year-over-year after reporting an EPS of $0.12 in its year-ago quarter. The negative growth rate signals that the Healthcare company isn't performing well amid current economic conditions.
Revenues were upbeat at $80.3 million. That is an increase of 5.51% in revenues from the year-ago report and is 3.97% higher than consensus estimates set at $77.3 million.
The stock is down 1.10% to $21.48 after the report.
Despite revenues increasing, earnings decreased, signaling a decline in profit margins.
The average recommendation from Wall Street analysts was a Buy which may get revised based on this new data.
Trading in the five days leading up to the report earned Artivion Inc a Bullish Sentiment Rank from InvestorsObserver.
Prior to the report, InvestorsObserver gave the stock an overall score of 44. Meanwhile, the average Wall Street analyst rated the stock a Buy.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others.